Hepion Pharmaceuticals, Inc.

HEPA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$406$14,786$51,189$91,349
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,207$2,702$5,307$6,103
Total Curr. Assets$1,614$17,488$56,496$97,452
Property Plant & Equip (Net)$0$242$3,322$456
Goodwill$0$0$0$1,871
Intangibles$0$0$3,190$3,190
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$364-$2,764$583
Total NC Assets$0$607$3,748$6,100
Other Assets$0$0$0$0
Total Assets$1,614$18,094$60,244$103,552
Liabilities
Payables$220$2,349$2,666$2,446
Short-Term Debt$2,900$116$54$267
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$24$2,825$5,166$5,494
Total Curr. Liab.$3,144$5,290$7,886$8,206
LT Debt$0$93$0$50
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$409$0
Other NC Liab.$333$5,430$2,094$2,300
Total NC Liab.$333$5,523$2,503$2,351
Other Liabilities$0$0$0$0
Cap. Leases$0$209$54$317
Total Liabilities$3,477$10,814$10,389$10,557
Equity
Pref Stock$1,695$1,695$1,696$1,701
Common Stock$0$0$0$8
Retained Earnings-$237,820-$224,627-$175,701-$133,501
AOCI$8-$79-$90$0
Other Equity$234,253$230,291$223,951$224,787
Total Equity-$1,863$7,281$49,856$92,995
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,614$18,094$60,244$103,552
Net Debt$2,494-$14,577-$51,135-$91,032